---
title: "Hong Kong Stocks Extend Gains Wednesday; Pop Mart, CSPC Earnings Miss Estimates"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280440988.md"
description: "Hong Kong Stocks Extend Gains Wednesday; Pop Mart, CSPC Earnings Miss Estimates"
datetime: "2026-03-25T08:55:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280440988.md)
  - [en](https://longbridge.com/en/news/280440988.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280440988.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280440988.md) | [繁體中文](https://longbridge.com/zh-HK/news/280440988.md)


# Hong Kong Stocks Extend Gains Wednesday; Pop Mart, CSPC Earnings Miss Estimates

Hong Kong Stocks Extend Gains Wednesday; Pop Mart, CSPC Earnings Miss Estimates

### 相关股票

- [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/zh-CN/quote/159506.CN.md)
- [Penghua CSI HK Connect Health Care Composite ETF (513700.CN)](https://longbridge.com/zh-CN/quote/513700.CN.md)
- [TRACKER FUND (02800.HK)](https://longbridge.com/zh-CN/quote/02800.HK.md)
- [FL2 CSOP HSI (07200.HK)](https://longbridge.com/zh-CN/quote/07200.HK.md)
- [FI CSOP HSI (07300.HK)](https://longbridge.com/zh-CN/quote/07300.HK.md)
- [China Southern Hang Seng ETF (513600.CN)](https://longbridge.com/zh-CN/quote/513600.CN.md)
- [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-CN/quote/159316.CN.md)
- [ChinaAMC Hang Seng ETF (159920.CN)](https://longbridge.com/zh-CN/quote/159920.CN.md)
- [CSOP HSI ETF (03037.HK)](https://longbridge.com/zh-CN/quote/03037.HK.md)
- [Hang Seng Index (00HSI.HK)](https://longbridge.com/zh-CN/quote/00HSI.HK.md)
- [ISHARESHSI (03115.HK)](https://longbridge.com/zh-CN/quote/03115.HK.md)
- [POP MART (09992.HK)](https://longbridge.com/zh-CN/quote/09992.HK.md)
- [CSPC PHARMA (01093.HK)](https://longbridge.com/zh-CN/quote/01093.HK.md)
- [FI2 CSOP HSI (07500.HK)](https://longbridge.com/zh-CN/quote/07500.HK.md)
- [Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII) (520500.CN)](https://longbridge.com/zh-CN/quote/520500.CN.md)
- [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-CN/quote/520880.CN.md)
- [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-CN/quote/520690.CN.md)
- [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/zh-CN/quote/513120.CN.md)
- [China Universal CNI HK Connect Innovative Drugs Industry ETF (159570.CN)](https://longbridge.com/zh-CN/quote/159570.CN.md)

## 相关资讯与研究

- [Pop Mart shares sink despite revenue surge, as analysts say Labubu reliance worries investors](https://longbridge.com/zh-CN/news/280487493.md)
- [CSPC Pharma's Profit Falls 10% in 2025; Misses EPS, Revenue Estimates](https://longbridge.com/zh-CN/news/280415449.md)
- [Pop Mart Revenue Tops 30 Billion Net Profit Surges 284%, Why Did Stock Price Plummet 15%?](https://longbridge.com/zh-CN/news/280420484.md)
- [Labubu maker Pop Mart meets 2025 revenue expectations](https://longbridge.com/zh-CN/news/280414763.md)
- [Pop Mart International Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025](https://longbridge.com/zh-CN/news/280465412.md)